Notice2024-30604
Advisory Council on Blood Stem Cell Transplantation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 23, 2024
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary's Advisory Council on Blood Stem Cell Transplantation (ACBSCT or Council) has scheduled a public meeting. Information about ACBSCT and the agenda for the meeting can be found on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/ advisory-council.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 246 (Monday, December 23, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Page 104550]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-30604]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Council on Blood Stem Cell Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Advisory Council on Blood Stem
Cell Transplantation (ACBSCT or Council) has scheduled a public
meeting. Information about ACBSCT and the agenda for the meeting can be
found on the ACBSCT website at <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
DATES: Thursday, January 23, 2025, 3:00 p.m.-5:00 p.m. Eastern Standard
Time.
ADDRESSES: This meeting will be held virtually by webinar. A link to
register and join the meeting will be posted at least 10 days prior to
the meeting at <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant, Designated Federal
Official, Division of Transplantation, Health Systems Bureau, HRSA,
5600 Fishers Lane, 8W-67, Rockville, Maryland 20857; 301-443-8036; or
<a href="/cdn-cgi/l/email-protection#1a5b595849594e5248495b5a7268697b347d756c"><span class="__cf_email__" data-cfemail="83c2c0c1d0c0d7cbd1d0c2c3ebf1f0e2ade4ecf5">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: ACBST provides advice and recommendations to
the Secretary of HHS (Secretary) on policy, program development, and
other matters of significance concerning the activities under the
authority of 42 U.S.C. 274k (Section 379 of the Public Health Service
Act), Public Law 109-129, as amended. The Council may transmit its
recommendations through the Administrator of HRSA on matters related to
the activities of the C.W. Bill Young Cell Transplantation Program and
National Cord Blood Inventory.
The agenda for the January 23, 2025, meeting is being finalized and
may include the following topics: graft versus host disease and late
effects, strategies for selecting cord blood units for transplantation,
HHS' approach for reviewing the state of the science and
recommendations on the appropriateness of the inclusion of adult stem
cells and birthing tissues as new types of therapies in the C.W. Bill
Young Cell Transplantation Program, and other areas to increase blood
stem cell donation and transplantation. Agenda items are subject to
change as priorities dictate. Refer to ACBSCT's website for any updated
information concerning the meeting. Members of the public will have the
opportunity to provide comments. Public participants may submit written
statements in advance of the scheduled meetings; oral comments will be
honored in the order they are requested and may be limited as time
allows. Requests to submit a written statement or make oral comments to
ACBSCT should be sent to Shelley Tims Grant, using the contact
information above at least 3 business days prior to the meeting.
Individuals who plan to attend and need special assistance or other
reasonable accommodations should notify ACBSCT at the address and phone
number listed above at least 10 business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-30604 Filed 12-20-24; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 23, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.